GASTRIC INTESTINAL METAPLASIA
Clinical trials for GASTRIC INTESTINAL METAPLASIA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC INTESTINAL METAPLASIA trials appear
Sign up with your email to follow new studies for GASTRIC INTESTINAL METAPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bile acid pill may reverse stomach precancer in new trial
Disease control Recruiting nowThis study tests whether ursodeoxycholic acid, a drug used for bile duct problems, can reverse gastric intestinal metaplasia—a condition that raises stomach cancer risk. About 196 adults without H. pylori infection will take the drug or a placebo daily for 6 months. Doctors will …
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated May 17, 2026 05:21 UTC
-
Could a common drug stop stomach cancer before it starts?
Disease control Recruiting nowThis study tests whether the drug pyrvinium can reverse early changes in the stomach lining that may lead to cancer. About 32 adults with a high-risk precancerous condition called gastric intestinal metaplasia will receive either the drug or a placebo. The goal is to see if the d…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Phase: PHASE2 • Sponsor: Katherine Garman • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New study aims to stop stomach cancer before it starts
Knowledge-focused Recruiting nowThis study is building a registry of people with early stomach changes that can lead to cancer, such as gastric atrophy or intestinal metaplasia. Researchers will also include healthy people and those with stomach cancer for comparison. The goal is to learn what makes these early…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:22 UTC